Serum Total and HDL-Cholesterol in Ischemic and Hemorrhagic Stroke
|
|
|
- Thomas Gilbert
- 9 years ago
- Views:
Transcription
1 Original Article Serum Total and HDL-Cholesterol in Ischemic and Hemorrhagic Abstract Objective: To determine frequency of dyslipidemia (hypercholesterolemia or low HDL- Cholesterol) among strokes patients and compare frequency of dyslipidemia between ischemic and hemorrhagic strokes patients. Study design: Descriptive case series Setting and Duration of Study: Department of Medicine, Holy Family Hospital, Rawalpindi, from Jan to Dec Materials and Methods: 370 consecutive patients of stroke, both males and females, above 18 years of age were included in the study. Patients on lipid lowering therapy were excluded. Informed consent was obtained and data was collected on a written proforma. Serum samples for total cholesterol and HDL-C were obtained on the morning after overnight fast and CT scan brain was performed. Results: Based on Brain CT scan findings, 370 patients (229 females and 141 males) were divided into two groups, Ischemic stroke (190) and Hemorrhagic stroke (180). Mean age (yrs) of stroke patients was Mean total cholesterol level (mg/dl) was , whereas mean HDL-cholesterol level was Out of 370 patients, 88 (23.7%) patients presented with hypercholesterolemia (serum TC > 200 mg/dl) in which frequency of hypercholesterolemia was significantly higher (p-value 0.009) in patients with Ischemic stroke as compared to hemorrhagic stroke (29.4% Vs 17.8%). Similarly, out of 370 patients, 136 (36.7%) patients presented with reduced HDL-C levels (serum HDL-C < 35 mg/dl). Ischemic stroke patients had significantly more frequency (pvalue 0.005) of reduced HDL-C than hemorrhagic stroke patients (43.7% Vs 29.4%). Out of 370 patients, 18 (4.9%) patients had both hypercholesterolemia and low HDL. Frequencies for other modifiable risk factors were 74.6% with hypertension, 28.3% with IHD, 20.5% diabetic and 17.8% cigarette smokers. Conclusions: Ischemic stroke patients had significantly higher frequency of hypercholesterolemia and reduced HDL-Cholesterol levels than patients of hemorrhagic stroke. Screening dyslipidemia for high risk patients for stroke and lipid lowering therapy are recommended as preventive measures. Key words:, Total Cholesterol, HDL-Cholesterol Muhammad Nazim Khan* Hina Dilruba Khan** Masood Ahmad*** Muhammad Umar**** *Assistant Professor of Surgery Department of Surgery RIHS (Bahria University), Islamabad. **Post Graduate Student ***Associate Professor of Medicine ****Professor of Medicine, Address for Correspondence Dr. Muhammad Nazim Khan Assistant Professor of Surgery Department of Surgery RIHS (Bahria University), Islamabad. [email protected] Introduction, also referred to as cerebrovascular accident (CVA) is the rapid loss of brain function due to disturbance in the blood supply to the brain. This can be due to ischemia caused by blockage (thrombosis, arterial embolism) or a hemorrhage. 1 is a global health problem. It is the leading cause of adult disability and the second leading cause of Ann. Pak. Inst. Med. Sci. 2014; 10(1)
2 mortality worldwide. 2 Between 1990 and 2010 the number of strokes decreased by approximately 10% in the developed world and increased by 10% in the developing world. 3 In the United States, stroke is a leading cause of disability, and recently declined from the third leading to the fourth leading cause of death. 4 There are no sizeable community based epidemiologic studies on stroke from Pakistan. A community based study on Pushtoon people residing in Karachi reported a prevalence of 4.8%, both for males and females. 5 is a medical emergency and can cause permanent neurological damage and death. There are various risk factors associated with stroke such as age, gender, race and ethnicity. There are also modifiable risk factors like hypertension, cardiac disease, diabetes mellitus, dyslipidemia, smoking, alcohol abuse, obesity, carotid stenosis, transient ischemic attack. Dyslipidemia is abnormal amounts of the lipids in the blood such as elevated plasma cholesterol and triglycerides or a low high-density lipoprotein (HDL) level that contributes to the development of atherosclerosis. Dyslipidemia can lead to symptomatic vascular disease, including coronary artery disease (CAD), stroke, and peripheral arterial disease. A linear relation probably exists between lipid levels and cardiovascular risk. However, the association between dyslipidemia and stroke may not be as straight forward as for coronary heart disease. Among various components of lipid profile, serum total cholesterol (TC) and HDL-C have attracted more attention. Large epidemiological studies in which ischemic and hemorrhagic strokes were distinguishable, have shown a modest association of elevated total cholesterol 6 as well as low HDL-C with increased risk of ischemic stroke. 7 Serum lipid levels have an established effect on short term morbidity due to strokes. It is important to evaluate the difference in serum lipid levels in subtypes of strokes to guide lipid-lowering therapy which can reduce incidence of stroke and related morbidity by adapting primary and secondary preventive measures. The objective of the study was to determine frequency of dyslipidemia among strokes patients and to compare frequency of dyslipidemia (hypercholesterolemia and low HDL-Cholesterol) between ischemic and hemorrhagic strokes patients. Materials and Methods The study was conducted at In-patient department of from Jan to Dec According to WHO sample size calculator, 370 stroke patients were included in the study, based on consecutive non-probability sampling technique. Inclusion criteria: Patients, both males and females, above 18 years of age, admitted with diagnosis of stroke were included in the study. Exclusion Criteria: Patients on lipid lowering therapy were excluded from study. Operational Definitions: was diagnosed on clinical assessment of neurological deficit, confirmed and subdivided into two groups, Ischemic and hemorrhagic stroke, based on findings of CT scan brain without contrast injection. Dyslipidemia was diagnosed on hypercholesterolemia and reduced HDL-Cholesterol only. Cut off levels were serum Total Cholesterol >200 mg/dl and serum HDL-Cholesterol <35 mg/dl respectively. Other lipid fractions like triglyceride, LDL and VLDL were not studied. Data Collection and Analysis Procedure: Informed consent was obtained from all participating patients. Demographic data was collected on a written proforma. Past medical and personal history for cigarette smoking, arterial hypertension, Diabetes mellitus and ischemic heart disease was sought. Serum samples were obtained after 8 hours of overnight fasting, on the next morning after admission. Data was analyzed using SPSS version 16. Chi-square test was used to compare frequency of hypercholesterolemia and low HDLcholesterol in Ischemic and Hemorrhagic stroke groups. P-value <0.05 was taken as significant. Results A total of 370 patients of stroke were enrolled in the study according to the inclusion and exclusion criteria of the study. Age of patients ranged from 20 to 95 years, in which mean + standard deviation of age (years) was Gender wise 229 (61.9%) were females and 141 (38.1%) males patients. Out of 370 patients, mean cholesterol level (mg/dl) was whereas mean HDL-cholesterol level was , as shown in Table No. I. Based on CT Brain findings of 370 stroke patients, the frequency of Ischemic was 190 (51.4%) and Hemorrhagic was 180 (48.6%) respectively. Out of 370 patients, 88 (23.7%) patients presented with hypercholesterolemia (serum TC > 200 mg/dl). Frequencies of hypercholesterolemia in Ischemic and hemorrhagic groups were 56 (29.4%) and 32 (17.8%) Ann. Pak. Inst. Med. Sci. 2014; 10(1)
3 respectively which was statistically significant (p-value 0.009) on comparison. Therefore, the frequency of hypercholesterolemia in patients with ischemic stroke was significantly higher than hemorrhagic stroke patients, as show in Table No. II. Table No I: Comparison of Total & HDL Cholesterol among stroke patients Total Cholesterol HDLcholesterol Minimu Maximu Standard n m m Mean Deviation Table No II: Comparison of Hypercholesterolemia among Subtypes of Patients Subtypes Ischemic Hemorrhagic P- Total Value Hypercholeste yes rolemia 29.4% 17.8% 23.7% (serum total cholesterol > no mg/dl) 70.6% 82.2% 76.3% Total % 100.0% 100.0% Similarly, out of 370 patients, 136 (36.7%) patients presented with reduced HDL-cholesterol levels. Frequency of reduced HDL-cholesterol level in ischemic and hemorrhaic groups were 83 (43.7%) and 53 (29.4%) respectively which was statistically significant (p-value 0.005) on comparison. Therefore, frequency of reduced HDL-cholesterol level in patients with Ischemic stroke was significantly more than Hemorrhagic stroke patients, as show in Table No. III. Frequency of dyslipidemia (stroke patients having both hypercholesterolemia and reduced HDL) was 18 (4.9%). Frequencies for other effect modifiers were also calculated. 276 (74.6%) stroke patients had hypertension, 105 (28.3%) ischemic heart disease (IHD), 76 (20.5%) diabetes mellitus and 66 (17.8%) patients were cigarette smokers. Table No. III: Comparison of Reduced HDL Cholesterol in subtypes of stroke patients Subtypes Reduced HDLcholesterol (serum HDLcholesterol < 35 mg/dl) Ischemic Hemorrhagic Discussion Total yes % 29.4% 36.8% no % 70.6% 63.2% Total % 100.0% 100.0% P- Value is a global health burden. is not only a traumatic event for the patient himself but also a source of major concern for the family and care providers. This also put the health care system under great stress. Developing countries like Pakistan who are already over burdened with health care budget, will find it difficult to cope up with increasing number of stroke patients. Mean age of our stroke patients for both males and females was which is slightly lower than 60.8 years quoted by Iqbal F 8 with a range between years Advanced age is one of the most significant stroke risk factors. Between 1990 and 2010, globally two-thirds of strokes occurred in those over the age of Peak incidence of stroke (32.4%) involved patients above 65 years old in our study which is comparable with findings of years of most vulnerable age group for stroke in another study. 14 We encountered higher number of patients with hemorrhagic stroke (48.6%) than some of other hospital based studies (22-31%) Dyslipidemia is a primary major risk factor for CAD and ischemic stroke 15. It causes insulin resistance which results in increased levels of plasma triglycerides and low-density lipoprotein cholesterol (LDL-C) and a decreased concentration of HDL-C, as an important risk factor for peripheral vascular disease 16, stroke, and CAD. 17 Serum HDL-cholesterol has anti-atherogenic properties with ability to trigger the flux of cholesterol from peripheral cells to the liver and thus having a protective effect. 18 Studies from neighboring countries like India 19 and Bangladesh 20 found a statistically positive correlation between elevated serum Total cholesterol and stroke. Ann. Pak. Inst. Med. Sci. 2014; 10(1)
4 The reported frequency for dyslipidemia in some of local studies on stroke patients includes 9.9% 21, 18% 22 and 57.5% 23. We found dyslipidemia to be the second most frequent modifiable risk factor for stroke after hypertension. Our frequency of 60.5% for dyslipidemia (23.7% hypercholesterolemia and 36.8% reduced HDL together) stands close to 60.7% reported by Ahmad 24 from Islamabad. Similarly, our frequency for hypercholesterolemia (23.7%) is slightly higher than 21% reported by Mahmood et al. 25 On comparison, Ischemic stroke patients had statistically significant higher levels of serum total cholesterol than patients with hemorrhagic stroke (29.4% Vs 17.9%). Similarly, patients with Ischemic stroke had significantly lower HDL-cholesterol levels than those with hemorrhagic stroke (43.7% Vs 29.4%). Arshad Mahmood 25 reported similar results. Burden of other major vascular risk factors i.e. hypertension, diabetes mellitus, and smoking is enormous in Pakistan. Hypertension is the most important modifiable risk factors for both ischemic and hemorrhagic stroke 26. A cross sectional survey at a community health center in a tertiary care hospital revealed 19% prevalence for hypertension among healthy adults presented for routine preventive checkups. Only 40% of hypertensive patients had controlled blood pressure. 27 Jaffar 28 similarly reported that more than 70% of people with hypertension were unaware of their condition, and less than 3% had adequately controlled blood pressure. 276(74.6%) of our stroke patients were hypertensive. This is in consistence with previously published studies in Pakistan. 23,24,29,30 Diabetes mellitus is another known modifiable risk factor for stroke. Pakistan has more than 5 millions diabetic patients which is expected to rise to 3.9 millions by 2020, leading Pakistan to 4th most populous country accommodating patients with diabetes mellitus (20.5%) of our patients were diabetic. Others found frequency of 39.2% 29 and 26.3% 30 for diabetes. Ischemic heart disease (IHD) is an important vascular disorder which increases the risk of ischemic stroke. In a population-based cross-sectional survey in Karachi, among 320 randomly selected adults aged 40 years or above, the overall prevalence of IHD was 26.9% % of the studied patients had Ischemic heart disease. This is in line with figures of 22% % 24 and 30% 23 from some of Pakistani studies. Cigarette smoking is a powerful risk factor, especially for MI, peripheral artery disease, and stroke. 34 Smoking has a negative effect of HDL-cholesterol and LDL-C to HDL- C ratio. Based on the data of National Health Survey of Pakistan, the overall prevalence of smoking among individuals aged 15 years or older was 15.2% % of stroke patients in the present study were smokers which is slightly lower than noted by others. 23,24 is costly and the cost in human terms, to patients and their families, is impossible to estimate. Prevention is therefore an important public health issue. Since association of dyslipidemia with risk of stroke is well established, therefore, high risk patients not only be screened for dyslipidemia but also treated by lipid lowering therapy like statins which reduce dyslipidemia related mortality by 24-29%. 36 Conclusion Ischemic stroke patients had significantly higher frequency of hypercholesterolemia and reduced HDL- Cholesterol levels than patients of hemorrhagic stroke. RECOMMENDATIONS: is costly; prevention is therefore an important public health concern. Screening for dyslipidemia in high risk patients as primary prevention and use of lipid lowering therapy as secondary prevention for stroke are strongly recommended. References 1. Sims NR, Muyderman H. Mitochondria, oxidative metabolism and cell death in stroke. Biochimica et Biophysica Acta. September 2009:1802 (1): Mathers, CD; Boerma, T; Ma Fat, D. Global and regional causes of death. British medical bulletin 2009:92: Feigin, Valery L; Forouzanfar, Mohammad H; Krishnamurthi, Rita; et al. Global and regional burden of stroke during : findings from the Global Burden of Disease Study The Lancet. 2013:(13) Towfighi A, Saver JL. declines from third to fourth leading cause of death in the United States: historical perspective and challenges ahead.. August 2011; 42(8): Jafar TH. Blood pressure, diabetes and increased dietary salt associated with stroke- results from a community-based study in Pakistan. J Hum Hypertens 2006;20: Ebrahim S, Sung J, Song YM, Ferrer RL, Lawlor DA, Davey Smith G. Serum cholesterol, haemorrhagic stroke, ischaemic stroke, and myocardial infarction: Korean national health system prospective cohort study. BMJ. 2006;333:22. Ann. Pak. Inst. Med. Sci. 2014; 10(1)
5 7. Sanossian N, Saver JL, Navab M, Ovbiagele B. High-density lipoprotein cholesterol: an emerging target for stroke treatment ;38: Iqbal F. Patient profile of 200 cases of stroke: A hospital based study. Shaikh Zayed Postgrad Med Inst. 2001; 15: Syed NA, Khealani BA, Ali S, Hasan A, Akhtar N, Brohi H et al. Ischemic stroke subtypes in Pakistan: the Aga Khan University Data Bank. J Pak Med Assoc. 2003; 53: Vohra EA, Ahmed WU, Ali M. Aetiology and prognostic factors of patients admitted for stroke. J Pak Med Assoc. 2000; 50: Khan H, Afridi AK, Ashraf S. A hospital based study on stratification of risk factors of stroke in Peshawar. Pak J Med Sci 2006;22: Alam I, Haider I, Wahab F, Khan W, Taqweem MA, Nowsherwan. Risk factors stratification in 100 patients of acute. J Postgrad Med Inst 2004;18: Qureshi M A, Jamshaid T D, Siddiqui A M. - A study of clinical patterns and risk factors. Ann King Edward Med Coll Jun 2003;9: Khan NI, Naz L, Mushtaq S, Rukh L, Ali S, Hussain Z. Ischaemic stroke: prevalence of modifiable risk factors in male and female patients in Pakistan. Pak J Pharm Sci 2009; 22: Nicholls S, Lundman P. The emerging role of lipoproteins in atherogenesis: beyond LDL cholesterol. Semin Vasc Med. 2004;4: Wild SH, Byrne CD, Tzoulaki I, et al. Metabolic syndrome, haemostatic and inflammatory markers, cerebrovascular and peripheral arterial disease: The Edinburgh Artery Study. Atherosclerosis. 2009;203: Rodriguez-Colon SM, Mo J, Duan Y, et al. Metabolic syndrome clusters and the risk of incident stroke: the atherosclerosis risk in communities (ARIC) study ;40: Jia L, Bai H, Fu M, Xu Y, Yang Y, Long S. Relationship between plasma HDL subclasses distribution and apoa-i gene polymorphisms. Clinica Chimica Acta 2005; 360: Sreedhar K, Srikant B, Joshi L, Usha G. Lipid profile in nondiabetic stroke--a study of 100 cases. J Assoc Physicians India Sep;58: Uddin MJ, Alam B, Jabbar MA, Mohammad QD, Ahmed S. Association of lipid profile with ischemic stroke. Mymensingh Med J Jul;18(2): Khan J, Rehman AU, Ali SA, Jielani A. Frequency of hypertension in stroke patients presenting at Ayub Teaching Hospital. J Ayub Med Coll Abbottabad 2006; 18: Kamal A, Aslam S, Khattak S. Frequency of risk factors in stroke patients admitted to DHQ teaching hospital D.I. khan. Gomal J Med Sci Jul - Dec 2010;8(2): Siddiqui M, Khan FS, Khatri IA. Clinical patterns and risk factors for stroke in 120 troke patients in a tertiary care hospital with designated stroke center. Pak J Neurol Sci. 2006;1: Ahmad A, Usman F, Hassan A. Risk factors and pattern of stroke in Islamabad. Rawal Med J. Jan - Jun 2009;34(1): Mahmood A, Sharif MA, Khan MN, Ali UZ. Comparison of Serum Lipid Profile in Ischaemic and Haemorrhagic. J Coll Physicians Surg Pak 2010, Vol. 20 (5): Khealani BA, Hameed B, Mapari UU, in Pakistan. J Pak Med Assoc July 2008;58:7: Iqbal SP, Dodani S, Qureshi R. Risk factors and behaviors for coronary artery disease (CAD) among ambulatory Pakistanis. J Pak Med Assoc 2004;54: Jafar TH, Levey AS, Jafary FH, White F, Gul A, Rahbar MH, et al. Ethnic subgroup differences in hypertension in Pakistan. J Hypertens 2003;21: Barech MS, Sadiq SM, Zarkoon AK, Dam G, Ullah K. Risk factors for ischemic stroke in patients attending a tertiary hospital in Quetta. Pak J Neurological Sci Jan - Mar 2010;5(1): Aquil N, Begum I, Ahmed A, Vohra EA, Soomro BA. Risk Factors in Various Subtypes of Ischemic According to TOAST Criteria J Coll Physicians Surg 2011, Vol. 21 (5): Jafar TH, Jafary FH, Jessani S, Chaturvedi N. Heart disease epidemic in Pakistan: women and men at equal risk. Am Heart J. 2005;150: Jafar TH, Chaturvedi N, Pappas G. Prevalence of overweight and obesity and their association with hypertension and diabetes mellitus in an Indo-Asian Population. CMAJ 2006;24: Basharat RA, Yousaf M, Iqbal J, Khan MM. Frequency of known risk factors for stroke in poor patients admitted to Lahore General Hospital in Pak J Med Sci 2002; 18: Karen L. Furie, Scott E. Kasner, Robert J. Adams et al. Attack: Guidelines for the Prevention of in Patients With or Transient Ischemic Attack: A Guideline for Healthcare Professionals From the American Heart Association/American Association ;42: Rizvi SF, Khan MA, Kundi A, Marsh DR, Samad A, Pasha O. Status of rheumatic heart disease in rural Pakistan. Heart 2004;90: Goldstein LB. Statins for stroke prevention. CurrAtheroscler Rep 2007; 9: Ann. Pak. Inst. Med. Sci. 2014; 10(1)
DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD
STROKE AND HEART DISEASE IS THERE A LINK BEYOND RISK FACTORS? D AN IE L T. L AC K L AN D DISCLOSURES Member of NHLBI Risk Assessment Workgroup RISK ASSESSMENT Count major risk factors For patients with
Main Effect of Screening for Coronary Artery Disease Using CT
Main Effect of Screening for Coronary Artery Disease Using CT Angiography on Mortality and Cardiac Events in High risk Patients with Diabetes: The FACTOR-64 Randomized Clinical Trial Joseph B. Muhlestein,
ROLE OF LDL CHOLESTEROL, HDL CHOLESTEROL AND TRIGLYCERIDES IN THE PREVENTION OF CORONARY HEART DISEASE AND STROKE
ROLE OF LDL CHOLESTEROL, HDL CHOLESTEROL AND TRIGLYCERIDES IN THE PREVENTION OF CORONARY HEART DISEASE AND STROKE I- BACKGROUND: Coronary artery disease and stoke are the major killers in the United States.
Role of Body Weight Reduction in Obesity-Associated Co-Morbidities
Obesity Role of Body Weight Reduction in JMAJ 48(1): 47 1, 2 Hideaki BUJO Professor, Department of Genome Research and Clinical Application (M6) Graduate School of Medicine, Chiba University Abstract:
Journal Club: Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy by the AIM-HIGH Investigators
Journal Club: Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy by the AIM-HIGH Investigators Shaikha Al Naimi Doctor of Pharmacy Student College of Pharmacy Qatar University
MY TYPE 2 DIABETES NUMBERS
BLOOD SUGAR MANAGEMENT GUIDE MY TYPE 2 DIABETES NUMBERS Understanding and Tracking the ABCs of Type 2 Diabetes 1 BLOOD MY TYPE SUGAR 2 DIABETES MANAGEMENT ABC NUMBERS GUIDE When you have type 2 diabetes,
Your healthcare provider has ordered a Boston Heart Cardiac Risk Assessment
Your healthcare provider has ordered a Boston Heart Cardiac Risk Assessment What does that mean for you? Your healthcare provider has determined that you may be at risk for cardiovascular disease (CVD).
Stroke: Major Public Health Burden. Stroke: Major Public Health Burden. Stroke: Major Public Health Burden 5/21/2012
Faculty Prevention Sharon Ewer, RN, BSN, CNRN Stroke Program Coordinator Baptist Health Montgomery, Alabama Satellite Conference and Live Webcast Monday, May 21, 2012 2:00 4:00 p.m. Central Time Produced
Metabolic Syndrome Overview: Easy Living, Bitter Harvest. Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007
Metabolic Syndrome Overview: Easy Living, Bitter Harvest Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007 Evolution of Metabolic Syndrome 1923: Kylin describes clustering
Guidelines for the management of hypertension in patients with diabetes mellitus
Guidelines for the management of hypertension in patients with diabetes mellitus Quick reference guide In the Eastern Mediterranean Region, there has been a rapid increase in the incidence of diabetes
Cardiovascular disease physiology. Linda Lowe-Krentz Bioscience in the 21 st Century October 14, 2011
Cardiovascular disease physiology Linda Lowe-Krentz Bioscience in the 21 st Century October 14, 2011 Content Introduction The number 1 killer in America Some statistics Recommendations The disease process
ADVANCE: a factorial randomised trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes
ADVANCE: a factorial randomised trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes Effects of a fixed combination of the ACE inhibitor, perindopril,
Osama Jarkas. in Chest Pain Patients. STUDENT NAME: Osama Jarkas DATE: August 10 th, 2015
STUDENT NAME: Osama Jarkas DATE: August 10 th, 2015 PROJECT TITLE: Analysis of ECG Exercise Stress Testing and Framingham Risk Score in Chest Pain Patients PRIMARY SUPERVISOR NAME: Dr. Edward Tan DEPARTMENT:
Achieving Quality and Value in Chronic Care Management
The Burden of Chronic Disease One of the greatest burdens on the US healthcare system is the rapidly growing rate of chronic disease. These statistics illustrate the scope of the problem: Nearly half of
How To Treat Dyslipidemia
An International Atherosclerosis Society Position Paper: Global Recommendations for the Management of Dyslipidemia Introduction Executive Summary The International Atherosclerosis Society (IAS) here updates
Coronary Heart Disease (CHD) Brief
Coronary Heart Disease (CHD) Brief What is Coronary Heart Disease? Coronary Heart Disease (CHD), also called coronary artery disease 1, is the most common heart condition in the United States. It occurs
Education. Panel. Triglycerides & HDL-C
Triglycerides & HDL-C Thomas Dayspring, MD, ACP Clinical Assistant Professor of Medicine University of Medicine and Dentistry of New Jersey Attending in Medicine: St Joseph s s Hospital, Paterson, NJ Certified
NCD for Lipids Testing
Applicable CPT Code(s): NCD for Lipids Testing 80061 Lipid panel 82465 Cholesterol, serum or whole blood, total 83700 Lipoprotein, blood; electrophoretic separation and quantitation 83701 Lipoprotein blood;
The International Agenda for Stroke
1st Global Conference on Healthy Lifestyles and Noncommunicable Diseases Control Moscow, 28-29 April, 2011 The International Agenda for Stroke Marc Fisher MD, University of Massachusetts Editor-in-Chief,
Listen to your heart: Good Cardiovascular Health for Life
Listen to your heart: Good Cardiovascular Health for Life Luis R. Castellanos MD, MPH Assistant Clinical Professor of Medicine University of California San Diego School of Medicine Sulpizio Family Cardiovascular
LIPID PANEL CHOLESTEROL LIPOPROTEIN, ELECTROPHORETIC SEPARATION LIPOPROTEIN, DIRECT MEASUREMENT (HDL) LDL DIRECT TRIGLYCERIDES
Test Code Test Name CPT CHOL Cholesterol, Serum 82465 HDL HDL, (High Density Lipoprotein) 83718 TRIG Triglycerides, Serum 84478 FTRIG Triglycerides (Fluid) 84478 LIPID Lipid Panel 80061 LDL LDL (Low Density
Psoriasis Co-morbidities: Changing Clinical Practice. Theresa Schroeder Devere, MD Assistant Professor, OHSU Dermatology. Psoriatic Arthritis
Psoriasis Co-morbidities: Changing Clinical Practice Theresa Schroeder Devere, MD Assistant Professor, OHSU Dermatology Psoriatic Arthritis Psoriatic Arthritis! 11-31% of patients with psoriasis have psoriatic
Barriers to Healthcare Services for People with Mental Disorders. Cardiovascular disorders and diabetes in people with severe mental illness
Barriers to Healthcare Services for People with Mental Disorders Cardiovascular disorders and diabetes in people with severe mental illness Dr. med. J. Cordes LVR- Klinikum Düsseldorf Kliniken der Heinrich-Heine-Universität
Diabetes and Heart Disease
Diabetes and Heart Disease Diabetes and Heart Disease According to the American Heart Association, diabetes is one of the six major risk factors of cardiovascular disease. Affecting more than 7% of the
MANAGEMENT OF LIPID DISORDERS: IMPLICATIONS OF THE NEW GUIDELINES
MANAGEMENT OF LIPID DISORDERS: IMPLICATIONS OF THE NEW GUIDELINES Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Declaration of full disclosure: No conflict of interest EXPLAINING
Type 1 Diabetes ( Juvenile Diabetes)
Type 1 Diabetes W ( Juvenile Diabetes) hat is Type 1 Diabetes? Type 1 diabetes, also known as juvenile-onset diabetes, is one of the three main forms of diabetes affecting millions of people worldwide.
Diabetes and Stroke. Understanding the connection between diabetes and the increased risk of stroke
Diabetes and Stroke Understanding the connection between diabetes and the increased risk of stroke Make the Connection Almost 26 million people in the U.S. roughly 8 percent of the population have diabetes.
Design and principal results
International Task Force for Prevention Of Coronary Heart Disease Coronary heart disease and stroke: Risk factors and global risk Slide Kit 1 (Prospective Cardiovascular Münster Heart Study) Design and
ESC/EASD Pocket Guidelines Diabetes, pre-diabetes and cardiovascular disease
Diabetes, prediabetes and cardiovascular disease Classes of recommendations Levels of evidence Recommended treatment targets for patients with diabetes and CAD Definition, classification and screening
Atherosclerosis of the aorta. Artur Evangelista
Atherosclerosis of the aorta Artur Evangelista Atherosclerosis of the aorta Diagnosis Classification Prevalence Risk factors Marker of generalized atherosclerosis Risk of embolism Therapy Diagnosis Atherosclerosis
Cohort Studies. Sukon Kanchanaraksa, PhD Johns Hopkins University
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this
Evaluation of Non-HDL-Cholesterol/HDL-cholesterol ratio as a predictor of coronary artery disease
Journal homepage: http://www.journalijar.com INTERNATIONAL JOURNAL OF ADVANCED RESEARCH RESEARCH ARTICLE Evaluation of Non-HDL-Cholesterol/HDL-cholesterol ratio as a predictor of coronary artery disease
Cardiovascular Disease Risk Factors
Cardiovascular Disease Risk Factors Risk factors are traits and life-style habits that increase a person's chances of having coronary artery and vascular disease. Some risk factors cannot be changed or
Multiple comorbidities: additive and predictive of cardiovascular risk. Peter M. Nilsson Lund University University Hospital Malmö, Sweden
Multiple comorbidities: additive and predictive of cardiovascular risk Peter M. Nilsson Lund University University Hospital Malmö, Sweden Clinical outcomes: major complications of CVD Heart Attack/ACS
ACUTE CORONARY SYNDROME By Dr wasfi al abadi md jbc, dr walid sawalha mbbs mrcp jbc
ACUTE CORONARY SYNDROME By Dr wasfi al abadi md jbc, dr walid sawalha mbbs mrcp jbc ABSTRACT Objective; In this study we looked at the demographic characteristics and the frequency of the various risk
4/4/2013. Mike Rizo, Pharm D, MBA, ABAAHP THE PHARMACIST OF THE FUTURE? METABOLIC SYNDROME AN INTEGRATIVE APPROACH
METABOLIC SYNDROME AN INTEGRATIVE APPROACH AN OPPORTUNITY FOR PHARMACISTS TO MAKE A DIFFERENCE Mike Rizo, Pharm D, MBA, ABAAHP THE EVOLUTION OF THE PHARMACIST 1920s 1960s 2000s THE PHARMACIST OF THE FUTURE?
The largest clinical study of Bayer's Xarelto (rivaroxaban) Wednesday, 14 November 2012 07:38
Bayer HealthCare has announced the initiation of the COMPASS study, the largest clinical study of its oral anticoagulant Xarelto (rivaroxaban) to date, investigating the prevention of major adverse cardiac
Obesity in the United States Workforce. Findings from the National Health and Nutrition Examination Surveys (NHANES) III and 1999-2000
P F I Z E R F A C T S Obesity in the United States Workforce Findings from the National Health and Nutrition Examination Surveys (NHANES) III and 1999-2000 p p Obesity in The United States Workforce One
YOUR GUIDE TO. Managing and Understanding Your Cholesterol Levels
YOUR GUIDE TO Managing and Understanding Your Cholesterol Levels Our goal at the Mercy Health Heart Institute is to help you be well. Our experienced team includes cardiologists, cardiovascular surgeons,
The Link Between Obesity and Diabetes The Rapid Evolution and Positive Results of Bariatric Surgery
The Link Between Obesity and Diabetes The Rapid Evolution and Positive Results of Bariatric Surgery Michael E. Farkouh, MD, MSc Peter Munk Chair in Multinational Clinical Trials Director, Heart and Stroke
Will The Coronary Calcium Score Affect the Decision To Treat With Statins?
Will The Coronary Calcium Score Affect the Decision To Treat With Statins? Amresh Raina M.D. Division of Cardiology University of Pennsylvania Disclosures No financial relationships relevant to this presentation
High Blood Cholesterol
National Cholesterol Education Program ATP III Guidelines At-A-Glance Quick Desk Reference 1 Step 1 2 Step 2 3 Step 3 Determine lipoprotein levels obtain complete lipoprotein profile after 9- to 12-hour
African Americans & Cardiovascular Diseases
Statistical Fact Sheet 2013 Update African Americans & Cardiovascular Diseases Cardiovascular Disease (CVD) (ICD/10 codes I00-I99, Q20-Q28) (ICD/9 codes 390-459, 745-747) Among non-hispanic blacks age
An Overview and Guide to Healthy Living with Type 2 Diabetes
MEETING YOUR GOALS An Overview and Guide to Healthy Living with Type 2 Diabetes MEETING YOUR GOALS This brochure was designed to help you understand the health goals to live a healthy lifestyle with type
Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II).
Complete Summary GUIDELINE TITLE (1)Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment
THE INTERNET STROKE CENTER PRESENTATIONS AND DISCUSSIONS ON STROKE MANAGEMENT
THE INTERNET STROKE CENTER PRESENTATIONS AND DISCUSSIONS ON STROKE MANAGEMENT Stroke Prevention in Atrial Fibrillation Gregory Albers, M.D. Director Stanford Stroke Center Professor of Neurology and Neurological
Secondary Stroke Prevention Luke Bradbury, MD 10/4/14 Fall WAPA Conferfence
Guidelines Secondary Stroke Prevention Luke Bradbury, MD 10/4/14 Fall WAPA Conferfence Stroke/TIA Nearly 700,000 ischemic strokes and 240,000 TIAs every year in the United States Currently, the risk for
Prescription Cholesterol-lowering Medication Use in Adults Aged 40 and Over: United States, 2003 2012
NCHS Data Brief No. 77 December 4 Prescription Cholesterol-lowering Medication Use in Adults Aged 4 and Over: United States, 3 2 Qiuping Gu, M.D., Ph.D.; Ryne Paulose-Ram, Ph.D., M.A.; Vicki L. Burt, Sc.M.,
Fewer people with coronary heart disease are being diagnosed as compared to the expected figures.
JSNA Coronary heart disease 1) Key points 2) Introduction 3) National picture 4) Local picture of CHD prevalence 5) Mortality from coronary heart disease in Suffolk County 6) Trends in mortality rates
HEDIS CY2012 New Measures
HEDIS CY2012 New Measures TECHNICAL CONSIDERATIONS FOR NEW MEASURES The NCQA Committee on Performance Measurement (CPM) approved five new measures for HEDIS 2013 (CY2012). These measures provide feasible
Hôpitaux Universitaires de Genève Lipides, métabolisme des hydrates de carbonne et maladies cardio-vasculaires
Hôpitaux Universitaires de Genève Lipides, métabolisme des hydrates de carbonne et maladies cardio-vasculaires Prof. J. Philippe Effect of estrogens on glucose metabolism : Fasting Glucose, HbA1c and C-Peptide
Your Life Your Health Cariodmetabolic Risk Syndrome Part VII Inflammation chronic, low-grade By James L. Holly, MD The Examiner January 25, 2007
Your Life Your Health Cariodmetabolic Risk Syndrome Part VII Inflammation chronic, low-grade By James L. Holly, MD The Examiner January 25, 2007 The cardiometabolic risk syndrome is increasingly recognized
Clinical Research on Lifestyle Interventions to Treat Obesity and Asthma in Primary Care Jun Ma, M.D., Ph.D.
Clinical Research on Lifestyle Interventions to Treat Obesity and Asthma in Primary Care Jun Ma, M.D., Ph.D. Associate Investigator Palo Alto Medical Foundation Research Institute Consulting Assistant
PRESCRIBING GUIDELINES FOR LIPID LOWERING TREATMENTS for SECONDARY PREVENTION
Hull & East Riding Prescribing Committee PRESCRIBING GUIDELINES FOR LIPID LOWERING TREATMENTS for SECONDARY PREVENTION For guidance on Primary Prevention please see NICE guidance http://www.nice.org.uk/guidance/cg181
How To Determine The Prevalence Of Microalbuminuria
Research Journal of Pharmaceutical, Biological and Chemical Sciences Prevalence of Microalbuminuria in relation to HbA1c among known Type2 Diabetic Patients in Puducherry population Muraliswaran P 1 *,
Why is HDL Cholesterol Low in People with Insulin Resistance and Type 2 Diabetes Mellitus?
Why is HDL Cholesterol Low in People with Insulin Resistance and Type 2 Diabetes Mellitus? Henry Ginsberg, MD Columbia University College of Physicians and Surgeons Henry Ginsberg: Disclosures Research
1. PATHOPHYSIOLOGY OF METABOLIC SYNDROME
1. PATHOPHYSIOLOGY OF METABOLIC SYNDROME Izet Aganović, Tina Dušek Department of Internal Medicine, Division of Endocrinology, University Hospital Center Zagreb, Croatia 1 Introduction The metabolic syndrome
Cardiovascular Disease in Diabetes
Cardiovascular Disease in Diabetes Where Do We Stand in 2012? David M. Kendall, MD Distinguished Medical Fellow Lilly Diabetes Associate Professor of Medicine University of MInnesota Disclosure - Duality
Prescription Pattern of Anti Hypertensive Drugs used in Hypertensive Patients with Associated Type2 Diabetes Mellitus in A Tertiary Care Hospital
Research Article Prescription Pattern of Anti Hypertensive Drugs used in Hypertensive Patients with Associated Type2 Diabetes Mellitus in A Tertiary Care Hospital *T. JANAGAN 1, R. KAVITHA 1, S. A. SRIDEVI
Assessing risk of myocardial infarction and stroke: new data from the Prospective Cardiovascular Münster (PROCAM) study
European Journal of Clinical Investigation (2007) 37, 925 932 DOI: 10.1111/j.1365-2362.2007.01888.x Blackwell Publishing Ltd Review Assessing risk of myocardial infarction and stroke: new data from the
Prognostic impact of uric acid in patients with stable coronary artery disease
Prognostic impact of uric acid in patients with stable coronary artery disease Gjin Ndrepepa, Siegmund Braun, Martin Hadamitzky, Massimiliano Fusaro, Hans-Ullrich Haase, Kathrin A. Birkmeier, Albert Schomig,
Cardiac Assessment for Renal Transplantation: Pre-Operative Clearance is Only the Tip of the Iceberg
Cardiac Assessment for Renal Transplantation: Pre-Operative Clearance is Only the Tip of the Iceberg 2 nd Annual Duke Renal Transplant Symposium March 1, 2014 Durham, NC Joseph G. Rogers, M.D. Associate
6/5/2014. Objectives. Acute Coronary Syndromes. Epidemiology. Epidemiology. Epidemiology and Health Care Impact Pathophysiology
Objectives Acute Coronary Syndromes Epidemiology and Health Care Impact Pathophysiology Unstable Angina NSTEMI STEMI Clinical Clues Pre-hospital Spokane County EMS Epidemiology About 600,000 people die
Substandard Underwriting Structured Settlements
Substandard Underwriting Structured Settlements Structures 101-Back to Basics February 20-22, 2013 Las Vegas, Nevada Rosemary Brindamour BSN CSSC Chief Medical Underwriter Structured Settlement Underwriting
Your Guide to Express Critical Illness Insurance Definitions
Your Guide to Express Critical Illness Insurance Definitions Your Guide to EXPRESS Critical Illness Insurance Definitions This guide to critical illness definitions will help you understand the illnesses
DEVELOPMENT AND VALIDATION OF AN INSTRUMENT TO ASSESS GENERAL KNOWLEDGE OF STROKE
DEVELOPMENT AND VALIDATION OF AN INSTRUMENT TO ASSESS GENERAL KNOWLEDGE OF STROKE Jeerapa Laosap 1, Piyarat Nimpitakpong 2, Chuenjid Kongkaew 2, Arom Jedsadayanmata 2, * 1 Department of Community Pharmacy,
Mortality Associated with Diabetes
Mortality Associated with Diabetes A review paper prepared for the 7th Global Conference of Actuaries, New Delhi, 15-16 February, 2005 Dr. David Muiry, MB;BS, FIA, FASI [email protected] Introduction
International Task Force for Prevention Of Coronary Heart Disease. Clinical management of risk factors. coronary heart disease (CHD) and stroke
International Task Force for Prevention Of Coronary Heart Disease Clinical management of risk factors of coronary heart disease and stroke Economic analyses of primary prevention of coronary heart disease
Understanding diabetes Do the recent trials help?
Understanding diabetes Do the recent trials help? Dr Geoffrey Robb Consultant Physician and Diabetologist CMO RGA UK Services and Partnership Assurance AMUS 25 th March 2010 The security of experience.
PHARMACOLOGICAL Stroke Prevention in Atrial Fibrillation STROKE RISK ASSESSMENT SCORES Vs. BLEEDING RISK ASSESSMENT SCORES.
PHARMACOLOGICAL Stroke Prevention in Atrial Fibrillation STROKE RISK ASSESSMENT SCORES Vs. BLEEDING RISK ASSESSMENT SCORES. Hossam Bahy, MD (1992 2012), 19 tools have been identified 11 stroke scores 1
25-hydroxyvitamin D: from bone and mineral to general health marker
DIABETES 25 OH Vitamin D TOTAL Assay 25-hydroxyvitamin D: from bone and mineral to general health marker FOR OUTSIDE THE US AND CANADA ONLY Vitamin D Receptors Brain Heart Breast Colon Pancreas Prostate
The Initial and 24 h (After the Patient Rehabilitation) Deficit of Arterial Blood Gases as Predictors of Patients Outcome
Biomedical & Pharmacology Journal Vol. 6(2), 259-264 (2013) The Initial and 24 h (After the Patient Rehabilitation) Deficit of Arterial Blood Gases as Predictors of Patients Outcome Vadod Norouzi 1, Ali
Mississippi Delta Health Collaborative Mississippi State Department of Health 1
The Impact of Community Health Workers on Cardiovascular Risk Reduction : Findings from the Clinical Community Health Worker Initiative Mississippi Delta Health Collaborative Mississippi State Department
Cardiovascular Risk in Diabetes
Cardiovascular Risk in Diabetes Lipids Hypercholesterolaemia is an important reversible risk factor for cardiovascular disease and should be tackled aggressively in all diabetic patients. In Type 1 patients,
Making Sense of the New Statin guidelines. They are more than just lowering your cholesterol!
Making Sense of the New Statin guidelines They are more than just lowering your cholesterol! No Disclosures Margaret (Peg) O Donnell DNPs, FNP, ANP B-C, FAANP Senior Nurse Practitioner South Nassau Communities
ELEMENTS FOR A PUBLIC SUMMARY. Overview of disease epidemiology. Summary of treatment benefits
VI: 2 ELEMENTS FOR A PUBLIC SUMMARY Bicalutamide (CASODEX 1 ) is a hormonal therapy anticancer agent, used for the treatment of prostate cancer. Hormones are chemical messengers that help to control the
LDL PARTICLE SIZE: DOES IT MATTER? Samia Mora, M.D., M.H.S., Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts.
LDL PARTICLE SIZE: DOES IT MATTER? Samia Mora, M.D., M.H.S., Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts Introduction While both small and large LDL particles may be atherogenic,
The New Complex Patient. of Diabetes Clinical Programming
The New Complex Patient as Seen Through the Lens of Diabetes Clinical Programming 1 Valerie Garrett, M.D. Medical Director, Diabetes Center at Mission Health System Nov 6, 2014 Diabetes Health Burden High
Health Risk Appraisal Profile
Language (Character Set): Health Risk Appraisal Profile Congratulations for completing your Health Risk Appraisal Questionnaire! Last update: June 4, 2012; 8:27:54 CDT This Health Risk Appraisal is not
THE NHS HEALTH CHECK AND INSURANCE FREQUENTLY ASKED QUESTIONS
THE NHS HEALTH CHECK AND INSURANCE FREQUENTLY ASKED QUESTIONS Introduction The following document has been produced by the Department of Health in partnership with the Association of British Insurers,
CASE B1. Newly Diagnosed T2DM in Patient with Prior MI
Newly Diagnosed T2DM in Patient with Prior MI 1 Our case involves a gentleman with acute myocardial infarction who is newly discovered to have type 2 diabetes. 2 One question is whether anti-hyperglycemic
TYPE 2 DIABETES MELLITUS: NEW HOPE FOR PREVENTION. Robert Dobbins, M.D. Ph.D.
TYPE 2 DIABETES MELLITUS: NEW HOPE FOR PREVENTION Robert Dobbins, M.D. Ph.D. Learning Objectives Recognize current trends in the prevalence of type 2 diabetes. Learn differences between type 1 and type
How To Know If You Have Microalbuminuria
3 PREVALENCE AND PREDICTORS OF MICROALBUMINURIA IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A CROSS-SECTIONAL OBSERVATIONAL STUDY Dr Ashok S Goswami *, Dr Janardan V Bhatt**; Dr Hitesh Patel *** *Associate
Freiburg Study. The other 24 subjects had healthy markers closer to what would be considered ideal.
Freiburg Study The Freiburg Study was conducted with 48 healthy human subjects of various ages. None of the test subjects had been diagnosed with any disease prior to the study. None were taking any type
Coronary Artery Disease leading cause of morbidity & mortality in industrialised nations.
INTRODUCTION Coronary Artery Disease leading cause of morbidity & mortality in industrialised nations. Although decrease in cardiovascular mortality still major cause of morbidity & burden of disease.
Vertebrobasilar Disease
The Vascular Surgery team at the University of Michigan is dedicated to providing exceptional treatments for in the U-M Cardiovascular Center (CVC), our new state-of-the-art clinical facility. Treatment
GENERAL HEART DISEASE KNOW THE FACTS
GENERAL HEART DISEASE KNOW THE FACTS WHAT IS Heart disease is a broad term meaning any disease affecting the heart. It is commonly used to refer to coronary heart disease (CHD), a more specific term to
Protein Intake in Potentially Insulin Resistant Adults: Impact on Glycemic and Lipoprotein Profiles - NPB #01-075
Title: Protein Intake in Potentially Insulin Resistant Adults: Impact on Glycemic and Lipoprotein Profiles - NPB #01-075 Investigator: Institution: Gail Gates, PhD, RD/LD Oklahoma State University Date
Metabolic Syndrome with Prediabetic Factors Clinical Study Summary Concerning the Efficacy of the GC Control Natural Blood Sugar Support Supplement
CLINICALLY T E S T E D Natural Blood Sugar Metabolic Syndrome with Prediabetic Factors Clinical Study Summary Concerning the Efficacy of the GC Control Natural Blood Sugar Metabolic Syndrome with Prediabetic
Community physicians knowledge of secondary prevention after ischemic stroke: a questionnaire survey in Shanxi Province, China
Chen et al. BMC Medical Education (2015) 15:197 DOI 10.1186/s12909-015-0481-4 RESEARCH ARTICLE Open Access Community physicians knowledge of secondary prevention after ischemic stroke: a questionnaire
Diabetes Complications
Managing Diabetes: It s s Not Easy But It s s Worth It Presenter Disclosures W. Lee Ball, Jr., OD, FAAO (1) The following personal financial relationships with commercial interests relevant to this presentation
Serum testosterone and short-term mortality in men with acute myocardial infarction
ORIGINAL ARTICLE Cardiology Journal 2010, Vol. 17, No. 3, pp. 249 253 Copyright 2010 Via Medica ISSN 1897 5593 Serum testosterone and short-term mortality in men with acute myocardial infarction Constantin
Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease
Home SVCC Area: English - Español - Português Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease Martial G. Bourassa, MD Research Center, Montreal Heart Institute, Montreal, Quebec,
